Reform of Medicare drug pricing is a hot topic in Congress this year.  While the majority of attention is focused on Part D, one of our Alliance physicians recommends Congress look to the efficacy and safety of the doctor’s office when they start looking for policy options in Part B.

Click here to access the OpEd.  

The Alliance Staff

Author The Alliance Staff

More posts by The Alliance Staff

Leave a Reply